The Pharma Data

JUNE 14, 2023

Pseudomonas aeruginosa, a common environmental bacterium, can colonize different body parts, such as the lungs, leading to persistent, chronic infections that can last a lifetime – a common occurrence in people with cystic fibrosis. This can lead to acute infection, and a person could develop sepsis that requires immediate treatment.

RNA 40

RNA Regulation Scientist Bacteria 40

pharmaphorum

MAY 31, 2022

billion in potential development milestones, to get its hands on the ASP3772 shot, which recently claimed a breakthrough designation from the FDA for the treatment of pneumococcal disease in older adults. GSK said it is paying $2.1 billion upfront for Cambridge, Massachusetts-based Affinivax, with another $1.2

Vaccination 52

Vaccination Vaccine Bacterium Sales 52

Pfizer

JANUARY 27, 2023

Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. An estimated 1.9 difficile may need to be discontinued.

Bacteria 75

Bacteria Medicine Containment Manufacturing 75

Roots Analysis

NOVEMBER 11, 2023

The Centers for Disease Control and Prevention (CDC) recently issued a formal health advisory in response to an unprecedented outbreak of carbapenem-resistant Pseudomonas aeruginosa (CRPA), a bacterium notorious for its resistance to specific antibiotics, thereby instigating severe infections in affected individuals.

Contamination 52

Contamination Bacterium Branding Bacteria 52

The Pharma Data

JULY 11, 2021

It is believed to be involved in the development of chronic inflammatory intestinal diseases, to trigger diabetes, to be responsible for obesity, even neurological diseases such as multiple sclerosis and Parkinson’s could have their causes here – not to mention depressions and autistic disorders.

Bacteria 52

Bacteria Genetics Scientist Regulation 52

pharmaphorum

JULY 14, 2021

Last year, Pfizer made almost $6 billion from its Prevnar 13 vaccine, which covers 13 common serotypes of Streptococcus pneumoniae – a bacteria which causes non-invasive illnesses like pneumonia, sinusitis and middle ear infections, as well as invasive diseases like meningitis. That is equivalent to 14% of Pfizer’s total revenues.

Immune Response 52

Immune Response Vaccine Vaccination Protein 52

The Pharma Data

NOVEMBER 26, 2020

Following on from last month’s announcement of execution of the definitive merger agreement with Longevity, today’s development constitutes another major stride towards attaining a NASDAQ listing, which will increase the pool of accessible capital and deliver value to the business and its shareholders,” said Duncan Peyton, CEO, 4D pharma.

Containment 52

Containment Bacterium Development Sales 52

The Pharma Data

MAY 13, 2021

The Colon Diseases You Develop When. and colon, is home for good and bad bacteria. It is this bacterium that. When your bad bacteria is in control in your gut, you will have constipation. is making your gut and your bacteria healthier. If you have constipation, most likely you have developed some hemorrhoids.

Doctors 52

Doctors Doctor Bacteria Production 52

XTalks

AUGUST 2, 2023

is a global pharmaceutical company, working across both developed and emerging markets. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharmaceutical Technology

JUNE 21, 2023

In a study published in Science Translational Medicine , researchers from Japan’s Nagoya University documented how Fusobacterium may play a key role in spurring the development of endometriosis. However, mounting evidence suggests that bacteria may also be involved.

Development 246

Development Hormones Bacteria Bacterium 246

XTalks

DECEMBER 24, 2020

Focusing on biologics, vaccine development and policy platforms in anticipation of an eventual outbreak is why we’re where we are today in terms of the positive side [of the pandemic].”. Most antibody drugs and vaccines have been developed to target parts of the spike protein. Pandemic Efforts. Diagnostics.

Life Science 111

Life Science Vaccine Vaccination Gene 111

XTalks

NOVEMBER 11, 2024

This theme addresses antimicrobial resistance (AMR), a critical issue where bacteria, viruses, fungi and parasites develop resistance to treatments, making infections harder — or sometimes impossible — to treat effectively. uUTIs are being increasingly caused by drug-resistant bacteria, leading to higher treatment failure rates.

Research 111

Research Bacteria Packaging Packaging 111